Mukhopadhyay, Bhaswati

Follow Mukhopadhyay, Bhaswati: Website |


QLT’s experimental eye drug could be worth up to $750 million

QLT’s experimental eye drug could be worth up to $750 million

December 10, 2012 6:31 pm by | 0 Comments

(Reuters) – Canadian eye drug developer QLT Inc expects its synthetic retinoid program, an experimental treatment for some inherited eye diseases that can cause blindness, to be valued at up to $750 million.
Several potential buyers have approached QL…